Featured Article
Researchers at the Hunan Normal University in China have discovered that the expression levels of a protein called retinitis pigmentosa GTPase regulator interacting protein 1-like (RPGRIP1L) may serve as a new prognostic marker for invasive breast cancer (BRCA).
Precision Oncology Today
Magazine
Beginning a New Era of Precision Alzheimer’s Therapeutics
Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
5 Startups With Proteomics Potential Attracting Investor Cash
Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...
Trending on Inside Precision Medicine
Combining Blood Test with Clinical Score Offers Breakthrough for Stroke Detection
Brigham and Women’s Hospital researchers say they have developed a test that combines a new blood-based test with a clinical score that can significantly shorten the time to diagnosing an aggressive type of stroke.
New Protein Marker Identified for Breast Cancer Prognosis
Researchers at the Hunan Normal University in China have discovered that the expression levels of a protein called retinitis pigmentosa GTPase regulator interacting protein 1-like (RPGRIP1L) may serve as a new prognostic marker for invasive breast cancer (BRCA).
Cord Blood Proteomic Profile May Help Predict Baby Growth Trajectories
Certain cord blood protein levels may be associated with birth weight and growth trajectories early in life, according to a new proteomics study.
